Alnylam Pharmaceuticals, Inc. (ALNY)
399.87
+2.22
(+0.56%)
USD |
NASDAQ |
Jan 02, 16:00
401.00
+1.13
(+0.28%)
After-Hours: 20:00
Alnylam Pharmaceuticals EPS Diluted (TTM): 0.2405 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 10.97 |
| Insmed, Inc. | -6.181 |
| Pfizer Inc. | 1.716 |
| Bristol Myers Squibb Co. | 2.962 |
| BridgeBio Pharma, Inc. | -4.187 |